These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12775314)

  • 41. Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
    James MP; Black MM; Sparkes CG
    Br J Dermatol; 1977 Mar; 96(3):303-5. PubMed ID: 322693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cushing's syndrome secondary to topical corticosteroids abuse.
    Ermis B; Ors R; Tastekin A; Ozkan B
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):795-6. PubMed ID: 12780758
    [No Abstract]   [Full Text] [Related]  

  • 43. Overview on desonide 0.05%: a clinical safety profile.
    Wong VK; Fuchs B; Lebwohl M
    J Drugs Dermatol; 2004; 3(4):393-7. PubMed ID: 15303783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
    Stein L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
    van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
    Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liquid chromatographic determination of clobetasone-17-butyrate in ointments.
    Patel AG; Patel RB; Patel MR
    J Assoc Off Anal Chem; 1990; 73(6):893-5. PubMed ID: 2289922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
    Seidenari S; Di Nardo A; Mantovani L; Giannetti A
    Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy of two topical corticosteroids in the management of chronic hand eczema.
    Gola M; D'Erme AM; Milanesi N
    G Ital Dermatol Venereol; 2015 Jun; 150(3):293-6. PubMed ID: 25946672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood.
    Queille C; Pommarede R; Saurat JH
    Pediatr Dermatol; 1984 Jan; 1(3):246-53. PubMed ID: 6494068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of dermatological conditions with a combination of an antibacterial agent, an antifungal agent and an antiinflammatory steroid.
    Franchi G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):488-90. PubMed ID: 4055161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, double-blind, multicenter trial comparing fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, applied twice daily for 4 weeks in the treatment of psoriasis.
    James M
    Cutis; 2001 Apr; 67(4 Suppl):2-9. PubMed ID: 11338723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
    Faghihi G; Iraji F; Shahingohar A; Saidat A
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of topical and systemic glucocorticosteroids on DNA synthesis in different tissues of the hairless mouse.
    Marshall RC; Burrows M; Brookes LG; du Vivier A
    Br J Dermatol; 1981 Nov; 105(5):517-20. PubMed ID: 7295568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Emovate in pediatric practice. A Swiss study on a new local corticosteroid].
    Graber W; Miescher A; Schneider HJ
    Ther Umsch; 1983 May; 40(5):449-53. PubMed ID: 6346567
    [No Abstract]   [Full Text] [Related]  

  • 57. Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.
    Yawalkar SJ; Schwerzmann L
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1163-6. PubMed ID: 1757610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.
    Reitamo S; Rustin M; Ruzicka T; Cambazard F; Kalimo K; Friedmann PS; Schoepf E; Lahfa M; Diepgen TL; Judodihardjo H; Wollenberg A; Berth-Jones J; Bieber T;
    J Allergy Clin Immunol; 2002 Mar; 109(3):547-55. PubMed ID: 11898005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
    Menter A
    Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis.
    Rajka G; Verjans HL
    J Int Med Res; 1986; 14(2):85-90. PubMed ID: 3516754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.